GIANNOTTA, CLAUDIA
GIANNOTTA, CLAUDIA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment
2024-01-01 Picca, Francesca; Giannotta, Claudia; Tao, Jiahao; Giordanengo, Lucia; Munir, H M Waqas; Botta, Virginia; Merlini, Alessandra; Mogavero, Andrea; Garbo, Edoardo; Poletto, Stefano; Bironzo, Paolo; Doronzo, Gabriella; Novello, Silvia; Taulli, Riccardo; Bersani, Francesca
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
2024-01-01 Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status
2022-01-01 Giannotta, Claudia; Castella, Barbara; Tripoli, Ezio; Grimaldi, Daniele; Avonto, Ilaria; D’Agostino, Mattia; Larocca, Alessandra; Kopecka, Joanna; Grasso, Mariella; Riganti, Chiara; Massaia, Massimo
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA
2022-01-01 C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia.
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT
2020-01-01 B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia.
MULTIFACETED IMMUNE CHECKPOINT EXPRESSION AND SENESCENT MARKERS IMPAIRS BONE MARROW Vγ9Vδ2 T-CELL FUNCTION IN MULTIPLE MYELOMA PATIENTS
2018-01-01 B Castella, C Riganti, M Foglietta, E Tripoli, C Giannotta, M Massaia
The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells
2023-01-01 Giannotta, Claudia; Autino, Federica; Massaia, Massimo
Untangling the immune suppressive network to accelerate the roadmap for a cure in human myeloma
2023-04-18
Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
2023-01-01 Giannotta, Claudia; Autino, Federica; Massaia, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment | 2024 | Picca, Francesca; Giannotta, Claudia; Tao, Jiahao; Giordanengo, Lucia; Munir, H M Waqas; Botta, Virginia; Merlini, Alessandra; Mogavero, Andrea; Garbo, Edoardo; Poletto, Stefano; Bironzo, Paolo; Doronzo, Gabriella; Novello, Silvia; Taulli, Riccardo; Bersani, Francesca | |
| Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma | 2024 | Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra | |
| Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status | 2022 | Giannotta, Claudia; Castella, Barbara; Tripoli, Ezio; Grimaldi, Daniele; Avonto, Ilaria; D’Agostino, Mattia; Larocca, Alessandra; Kopecka, Joanna; Grasso, Mariella; Riganti, Chiara; Massaia, Massimo | |
| IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA | 2022 | C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia. | |
| MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT | 2020 | B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia. | |
| MULTIFACETED IMMUNE CHECKPOINT EXPRESSION AND SENESCENT MARKERS IMPAIRS BONE MARROW Vγ9Vδ2 T-CELL FUNCTION IN MULTIPLE MYELOMA PATIENTS | 2018 | B Castella, C Riganti, M Foglietta, E Tripoli, C Giannotta, M Massaia | |
| The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells | 2023 | Giannotta, Claudia; Autino, Federica; Massaia, Massimo | |
| Untangling the immune suppressive network to accelerate the roadmap for a cure in human myeloma | 2023 | - | |
| Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? | 2023 | Giannotta, Claudia; Autino, Federica; Massaia, Massimo |